| Biomarker ID | 996 |
| PMID | 23046102 |
| Year | 2012 |
| Biomarker | GPX1 |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Blood |
| Subjects | Humans |
| Regulation | Upregulated in Metatstasis |
| Odds Ratio/Hazard Ratio/Relative Risk | OR: 4.3 |
| Effect on Pathways | Pathways inlcude: Cardiac protection against reactive oxygen species, Free radical-induced apoptosis, Arachidonic acid metabolism, Purine catabolism, Nucleotide metabolism |
| Experiment | Relpase Vs No Relapse |
| Type of Biomarker | Prognostic |
| Cohort | Study included 51 patients with distant relapse tumours, and 77 with no tumour relapse were included in the study. |
| Senstivity | 71% |
| Specificity | 65% |
| AUC | 0.755 |
| Accuracy | 67% |
| Level Of Significance | p<0.001 |
| Method Used | real-time reverse-transcriptase PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |